信立泰(002294.SZ)：筹划发行H股股票并在香港联合交易所上市

Core Viewpoint - The company, Shenzhen Sinopharm Co., Ltd., is planning to issue overseas shares (H-shares) and list on the Hong Kong Stock Exchange to advance its globalization strategy and support high-quality development [1] Group 1 - The company is currently in discussions with relevant intermediaries regarding the specifics of the issuance and listing process [1] - The details of the issuance and listing have not yet been finalized [1] - This issuance and listing will not result in changes to the company's controlling shareholder or actual controller [1]